Wenyi Hou

发表

Analysis of risk factors for early death in patients with acute promyelocytic leukaemia treated with arsenic trioxide

Yingmei Zhang, Yuanbo Wang, T. Hu, 2022, Annals of Hematology.

Characteristics of fibrinolytic disorders in acute promyelocytic leukemia

Jin Zhou, Yingmei Zhang, Hongli Zhao, 2018, Hematology.

Tissue factor–bearing microparticles are a link between acute promyelocytic leukemia cells and coagulation activation: a human subject study

Jin Zhou, Yingmei Zhang, Hongli Zhao, 2021, Annals of Hematology.

Comparative analysis of causes and predictors of early death in elderly and young patients with acute promyelocytic leukemia treated with arsenic trioxide

Jin Zhou, Yingmei Zhang, J. Hou, 2019, Journal of Cancer Research and Clinical Oncology.

Development of a risk grading system to identify patients with acute promyelocytic leukemia at high risk of early death

Jin Zhou, Yanqiu Zhao, Yingmei Zhang, 2018, Cancer management and research.

Causes and prognostic factors for early death in patients with acute promyelocytic leukemia treated with single-agent arsenic trioxide

Xiaoxia Li, Jin Zhou, Yingmei Zhang, 2017, Annals of Hematology.

Factors affecting thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone.

Jin Zhou, Yingmei Zhang, Hongli Zhao, 2019, Blood cells, molecules & diseases.

Difference in causes and prognostic factors of early death between cohorts with de novo and relapsed acute promyelocytic leukemia

Jin Zhou, Yanqiu Zhao, Yingmei Zhang, 2018, Annals of Hematology.

A novel strategy for enhancing inhibitor tolerance of gram-positive bacteria through overexpression of the peptidoglycan synthesis genes murG and mraY

Xiangqian Li, Jiaxing Xu, Ai-yong He, 2023, Industrial Crops and Products.